Thomas Zindrick - 01 Sep 2025 Form 4 Insider Report for GENELUX Corp (GNLX)

Role
President and CEO, Director
Signature
/s/ Thomas Zindrick
Issuer symbol
GNLX
Transactions as of
01 Sep 2025
Net transactions value
$0
Form type
4
Filing time
03 Sep 2025, 16:15:34 UTC
Previous filing
29 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Zindrick Thomas President and CEO, Director C/O GENELUX CORPORATION, 2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE /s/ Thomas Zindrick 03 Sep 2025 0001937573

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GNLX Stock Option (Right to Buy) Disposed to Issuer -925,000 -100% 0 01 Sep 2025 Common stock 925,000 $6.00 Direct F1, F2
transaction GNLX Stock Option (Right to Buy) Award +925,000 925,000 01 Sep 2025 Common stock 925,000 $3.33 Direct F1, F2
transaction GNLX Stock Option (Right to Buy) Disposed to Issuer -157,372 -100% 0 01 Sep 2025 Common stock 157,372 $6.00 Direct F1, F2
transaction GNLX Stock Option (Right to Buy) Award +157,372 157,372 01 Sep 2025 Common stock 157,372 $3.33 Direct F1, F2
transaction GNLX Stock Option (Right to Buy) Disposed to Issuer -23,568 -100% 0 01 Sep 2025 Common stock 23,568 $6.00 Direct F1, F2
transaction GNLX Stock Option (Right to Buy) Award +23,568 23,568 01 Sep 2025 Common stock 23,568 $3.33 Direct F1, F2
transaction GNLX Stock Option (Right to Buy) Disposed to Issuer -250,000 -100% 0 01 Sep 2025 Common stock 250,000 $22.40 Direct F2, F3
transaction GNLX Stock Option (Right to Buy) Award +250,000 250,000 01 Sep 2025 Common stock 250,000 $3.33 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to these options are fully vested.
F2 The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options.
F3 The shares subject to the option vest as follows: 25% on September 11, 2024, and the remaining shares vest in 36 equal monthly installments thereafter.